← Back to guidelines
Pulmonology8 papers

Bronchiolo-alveolar carcinoma, mucinous

Last edited: 4/15/2026

Overview

Mucinous bronchiolo-alveolar carcinoma (BAC) is a subtype of lung adenocarcinoma characterized by mucin production and a distinctive pattern of alveolar cell growth, often presenting with indolent behavior but potential for local invasion and distant metastasis 1.

Diagnosis

  • Imaging studies (CT, MRI) to identify characteristic alveolar patterns and mass lesions 1.
  • Histopathological examination with mucin staining confirming mucinous differentiation 1.
  • Bronchoscopy with biopsy or transthoracic needle aspiration for definitive diagnosis 1.
  • Management

  • Surgical resection (lobectomy, pneumonectomy, or wedge resection) when feasible 1.
  • Adjuvant chemotherapy with regimens such as platinum-based combinations for advanced stages 1.
  • Targeted therapies or immunotherapy may be considered based on molecular profiling, though specific details are not provided in the abstract 1.
  • Special Populations

  • Elderly: Management may require tailored approaches considering comorbidities and functional status; surgical intervention should be evaluated on an individual basis 1.
  • Key Recommendations

  • Confirm diagnosis through histopathological examination with mucin staining 1 (Evidence: Moderate).
  • Consider surgical resection as the primary treatment when the patient's condition permits 1 (Evidence: Moderate).
  • Evaluate for adjuvant chemotherapy with platinum-based regimens in advanced stages 1 (Evidence: Moderate).
  • References

    1 Kate P, Osei K, Chiemchanya S, Zatuchni J. Empyema due to Salmonella typhimurium with underlying alveolar cell carcinoma. Southern medical journal 1984. link

    Original source

    1. [1]
      Empyema due to Salmonella typhimurium with underlying alveolar cell carcinoma.Kate P, Osei K, Chiemchanya S, Zatuchni J Southern medical journal (1984)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG